NasdaqCM - Nasdaq Real Time Price USD
Bluejay Diagnostics, Inc. (BJDX)
1.9100
-0.0200
(-1.04%)
At close: 4:00:01 PM EDT
1.9600
+0.05
+(2.62%)
After hours: 5:26:49 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
249.0400
0
Cost of Revenue
--
--
0
200.1290
0
Gross Profit
--
--
0
48.9110
0
Operating Expense
6,630.4280
7,169.6160
10,311.2170
9,366.6870
3,155.1630
Operating Income
-6,630.4280
-7,169.6160
-10,311.2170
-9,317.7760
-3,155.1630
Net Non Operating Interest Income Expense
-689.4950
-677.2050
164.9000
89.6730
-367.4590
Other Income Expense
66.1590
129.0270
192.4290
-68.8450
34.3240
Pretax Income
-7,253.7640
-7,717.7940
-9,953.8880
-9,296.9480
-3,488.2980
Net Income Common Stockholders
-20,476.8170
-20,940.8470
-9,953.8880
-9,296.9480
-3,488.2980
Diluted NI Available to Com Stockholders
-20,476.8170
-20,940.8470
-9,953.8880
-9,296.9480
-3,488.2980
Basic EPS
277.20
-114.19
-3.63k
-3.68k
-3.28k
Diluted EPS
277.20
-114.19
-3.63k
-3.68k
-3.28k
Basic Average Shares
320.4200
183.3920
2.7410
2.5200
1.0650
Diluted Average Shares
320.4200
183.3920
2.7410
2.5200
1.0650
Total Operating Income as Reported
-6,630.4280
-7,169.6160
-10,311.2170
-9,317.7760
-3,230.1630
Total Expenses
6,630.4280
7,169.6160
10,311.2170
9,566.8160
3,155.1630
Net Income from Continuing & Discontinued Operation
-7,253.7640
-7,717.7940
-9,953.8880
-9,296.9480
-3,488.2980
Normalized Income
-7,253.7640
-7,717.7940
-9,953.8880
-9,059.6390
-3,488.2980
Interest Income
133.5330
145.8230
164.9000
89.6730
--
Interest Expense
--
823.0280
0
0
367.4590
Net Interest Income
-689.4950
-677.2050
164.9000
89.6730
-367.4590
EBIT
-6,355.5780
-6,894.7660
-9,953.8880
-9,317.7760
-3,120.8390
EBITDA
-6,158.9140
-6,695.6690
-9,172.9330
-9,011.4080
-2,975.1200
Reconciled Cost of Revenue
--
--
0
200.1290
0
Reconciled Depreciation
196.6640
199.0970
780.9550
306.3680
145.7190
Net Income from Continuing Operation Net Minority Interest
-7,253.7640
-7,717.7940
-9,953.8880
-9,296.9480
-3,488.2980
Total Unusual Items Excluding Goodwill
--
--
0
-237.3090
0
Total Unusual Items
--
--
0
-237.3090
0
Normalized EBITDA
-6,158.9140
-6,695.6690
-9,172.9330
-8,774.0990
-2,975.1200
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TIVC Tivic Health Systems, Inc.
4.4500
+3.73%
NAOV NanoVibronix, Inc.
1.2900
-0.77%
TNON Tenon Medical, Inc.
1.1700
+4.46%
VERO Venus Concept Inc.
2.3200
+5.45%
ALUR Allurion Technologies Inc.
3.1900
+4.25%
ADGM Adagio Medical Holdings, Inc.
1.1800
-2.48%
WOK WORK Medical Technology Group LTD
0.5056
-0.35%
MOVE Movano Inc.
0.7410
-17.48%
HSCS HeartSciences Inc.
4.4900
+18.47%
OPGN OpGen, Inc.
4.7400
-3.07%